Skip to main content

Diagnostic Accuracy and Safety of CT-Guided Percutaneous Transthoracic Needle Biopsies: 14-Gauge versus 22-Gauge Needles.

Ocak S, Duplaquet F, Jamart J, Pirard L, Weynand B, Delos M, Eucher P, Rondelet B, Dupont M, Delaunois L, Sibille Y, Dahlqvist C

Publication: J Vasc Interv Radiol (2016) • Vol 27 • Page 674-81PMID: 27017121View on PubMed

Purpose

This paper compared the diagnostic accuracy, sensitivity, specificity, and negative predictive values for malignancy of 14-gauge (G) core needle biopsies (CNB) and 22-G fine needle biopsies (FNB).

Conclusion

Use of a 14-G needle more frequently allowed for the collection of more than one specimen. However, 14-G CNB and 22-G FNB had comparable overall diagnostic accuracy, as well as cancer-specific diagnostic accuracy, sensitivity, specificity, and negative predictive value for malignancy. Importantly, it was possible to assign a defined cancer subtype in a significantly higher percentage of malignancies biopsied with a 14-G than a 22-G needle. 

Studies (1)

Purpose

This study compared the diagnostic accuracy, sensitivity, specificity, and negative predictive values for malignancy of computed tomography (CT)-guided transthoracic 14-G CNB and 22-G FNB. The 102 14-G CNB (99 patients) were performed using a 15 cm long Spirotome device by two physicians and the 102  22-G FNB (92 patients) were performed using a 15 cm Rotex device by three physicians. FNBs were fixed with lacquer or a 50% ethanol solution for cytological analysis and CNB were fixed in formalin.  Final diagnosis was determined by follow-up or by surgical resection.

Summary of Findings

Although more than 1 specimen was obtained from 92% of patients who underwent 14-G CNB, more than one specimen was obtained from only 22% of patients who underwent 22-G FNB (P<0.001). However, 14-G CNB and 22-G FNB had comparable overall diagnostic accuracy (90% versus 82%), as well as cancer-specific diagnostic accuracy (94% versus 89%), sensitivity (91% versus 84%), specificity (100% versus 93%), and negative predictive value (78% versus 50%) for malignancy. Importantly, it was possible to assign a defined cancer subtype in 69 of 71 (97%) malignancies biopsied with a 14-G needle but only 47 of 73 (67%) of malignancies biopsied with a 22-G FNB (P<0.001). While major complications occurred at comparable rates with the two needle types, partial pneumothorax occurred more frequently following 14-G CNB than 22-G FNB (24% versus 7%, P=0.002).

  • Biospecimens

    CellLung
    CellPleural Fluid
    TissueLung
  • Preservation Types

    EthanolOther PreservativeFormalin
  • Diagnoses

    NeoplasticCarcinoma
    NeoplasticBenign
    Emphysema
    Pneumonia/Respiratory Infection
    Not specified
  • Platforms

    MorphologyLight microscopy
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionNeedle gauge
    14-G CNB
    22-G FNB